Elisabeth Adams

Citado por

	Total	Desde 2020
Citas	1949	750
Índice h	20	14
Índice i10	28	23

200

100

150

20042005200620072008200920102011201220132014201520162017201820192020202120222023202420257 11 21 42 37 70 60 59 100 84 81 84 126 123 132 118 186 183 138 105 127 10

Acceso público

Ver todo

18 artículos

0 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Katy TurnerUniversity of BristolDirección de correo verificada de bristol.ac.uk
John EdmundsProfessor of Infectious Disease Modelling, London School of Hygiene and Tropical MedicineDirección de correo verificada de lshtm.ac.uk
Simon GoldenbergGuy's and St Thomas' NHS Foundation TrustDirección de correo verificada de gstt.nhs.uk
Susie HuntingtonAquarius Population HealthDirección de correo verificada de aquariusph.com
Michael J HarveyManager, Putnam AssociatesDirección de correo verificada de putassoc.com
Gwenda HughesLondon School of Hygiene & Tropical MedicineDirección de correo verificada de lshtm.ac.uk
Jeff RoundInstitute of Health EconomicsDirección de correo verificada de ihe.ca
Arminder K DeolLondon School of Hygiene & Tropical MedicineDirección de correo verificada de cepi.net
Vari M DrennanProfessor of Health Care & Policy Research , Joint Faculty of Kingston Univerity & St. George'sDirección de correo verificada de sgul.kingston.ac.uk
Rebecca E. GloverAssistant Professor of Public Health and Policy, London School of Hygiene and Tropical MedicineDirección de correo verificada de lshtm.ac.uk
Andres I. Vecino OrtizJohns Hopkins UniversityDirección de correo verificada de jhu.edu
Fiona ReidKing's College LondonDirección de correo verificada de kcl.ac.uk
Catherine H. MercerProfessor of Sexual Health Science, University College LondonDirección de correo verificada de ucl.ac.uk
Andre CharlettDepartment Head, Public Health EnglandDirección de correo verificada de phe.gov.uk
Charlotte JacksonSenior Research Fellow, MRC CTU at UCLDirección de correo verificada de ucl.ac.uk
Chih-Yuan ChengBoehringer IngelheimDirección de correo verificada de boehringer-ingelheim.com
Neil WoodfordUK Health Security AgencyDirección de correo verificada de phe.gov.uk
Ken EamesLecturer, London School of Hygiene and Tropical MedicineDirección de correo verificada de lshtm.ac.uk
Natasha Tilston-Lunel (Tilston)Department of Microbiology and Immunology, Indiana University School of MedicineDirección de correo verificada de iu.edu
Azra GhaniImperial College LondonDirección de correo verificada de imperial.ac.uk

Seguir

Elisabeth Adams

CEO, Aquarius Population Health

Dirección de correo verificada de aquariusph.com - Página principal

Chronic and infectious diseases modelling health economics consultancy research


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Estimating the costs of school closure for mitigating an influenza pandemic M Sadique, E Adams, W Edmunds BMC Public Health 8 (1), 135, 2008	253	2008
Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies EJ Adams, A Charlett, WJ Edmunds, G Hughes Sexually transmitted infections 80 (5), 354-362, 2004	227	2004
Using seroprevalence and immunisation coverage data to estimate the global burden of congenital rubella syndrome, 1996-2010: a systematic review E Vynnycky, EJ Adams, FT Cutts, SE Reef, AM Navar, E Simons, ... PloS one 11 (3), e0149160, 2016	154	2016
The cost-effectiveness of opportunistic chlamydia screening in England EJ Adams, KME Turner, WJ Edmunds Sexually transmitted infections, 2007	120	2007
Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! P Horner, K Blee, E Adams Current opinion in infectious diseases 27 (1), 68-74, 2014	115	2014
Modelling the effectiveness of chlamydia screening in England KME Turner, EJ Adams, DS LaMontagne, L Emmett, K Baster, ... Sexually transmitted infections 82 (6), 496-502, 2006	108	2006
The impact of illness and the impact of school closure on social contact patterns. KTD Eames, NL Tilston, PJ White, E Adams, WJ Edmunds Health technology assessment (Winchester, England) 14 (34), 267-312, 2010	101	2010
Theoretical Biology and Medical Modelling KME Turner, EJ Adams, N Gay, AC Ghani, C Mercer, WJ Edmunds Theoretical biology and medical modelling 3, 3, 2006	100*	2006
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary … KME Turner, J Round, P Horner, J Macleod, S Goldenberg, A Deol, ... Sex Transm Infect 90 (2), 104-111, 2014	94	2014
Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits GG Whitlock, DC Gibbons, N Longford, MJ Harvey, A McOwan, EJ Adams International journal of STD & AIDS 29 (5), 474-482, 2018	72	2018
Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study K Turner, E Adams, A Grant, J Macleod, G Bell, J Clarke, P Horner BMJ 342, c7250, 2011	67	2011
What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection … A Aghaizu, EJ Adams, K Turner, S Kerry, P Hay, I Simms, P Oakeshott Sexually Transmitted Infections 87 (4), 312-317, 2011	53	2011
Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Neisseria … KME Turner, H Christensen, EJ Adams, D McAdams, H Fifer, A McDonnell, ... BMJ open 7 (6), e015447, 2017	51	2017
The cost-effectiveness of syndromic management in pharmacies in Lima, Peru EJ Adams, PJ Garcia, GP Garnett, WJ Edmunds, KK Holmes Sexually Transmitted Diseases 30 (5), 379-387, 2003	43	2003
Mapping patient pathways and estimating resource use for point of care versus standard testing and treatment of chlamydia and gonorrhoea in genitourinary medicine clinics in the UK EJ Adams, A Ehrlich, KME Turner, K Shah, J Macleod, S Goldenberg, ... BMJ open 4 (7), e005322, 2014	42	2014
Modelling the healthcare costs of an opportunistic chlamydia screening programme EJ Adams, DS LaMontagne, AR Johnston, JM Pimenta, KA Fenton, ... Sexually transmitted infections 80 (5), 363-370, 2004	37	2004
The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland P Gillespie, C O'Neill, E Adams, K Turner, D O'Donovan, R Brugha, ... Sexually transmitted infections 88 (3), 222-228, 2012	34	2012
Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary … SE Huntington, RM Burns, E Harding-Esch, MJ Harvey, R Hill-Tout, ... BMJ open 8 (9), e020394, 2018	30	2018
Prospective evaluation of the cost of diagnosis and treatment of invasive fungal disease in a cohort of adult haematology patients in the UK MM Ceesay, Z Sadique, R Harris, A Ehrlich, EJ Adams, A Pagliuca Journal of Antimicrobial Chemotherapy 70 (4), 1175-1181, 2015	29	2015
Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based … G Weston, C Dombrowski, MJ Harvey, T Iftner, M Kyrgiou, C Founta, ... BMJ open 10 (3), e031303, 2020	25	2020

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores